Accendra Health vs 111
Accendra Health is the larger business, with $2.76bn of revenue in fiscal 2025 against $1.75bn for 111 (1.6 times as much). Accendra Health grew faster (3.1% against -12.7%). 111 kept more of each dollar of sales as profit: a net margin of -0.5% against -39.8%.
| Latest fiscal year | Accendra HealthACH, 2025 | 111YI, 2025 |
|---|---|---|
| Revenue | $2.76bn | $1.75bn |
| Revenue growth | 3.1% | -12.7% |
| Net income | −$1.10bn | −$9.2m |
| Operating margin | 1.0% | -0.0% |
| Net margin | -39.8% | -0.5% |
| Return on equity | — | — |
| Free cash flow | −$293m | $16.0m |
| Cash | $282m | $73.1m |
| Total debt | $2.05bn | $26.8m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $10.2m | — |
| Employees | 6,500 | — |
| Market value | $20.0m | $25.4m |
| Price vs our value range | — | — |
| Moat score | 17 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 36 sales |